‹ Back to INDGN.NS

INDGN.NS Profit & Loss

Indegene Ltd.

Profit & Loss Balance Sheet Cash Flow

Profit & Loss · 3 years on file (FY2023-24 to FY2025-26) · fetched 2026-08-24 01:38
Line item FY2023-24 FY2024-25 FY2025-26 Source (XBRL element)
Revenue from Operations ₹25.90 Bn ₹28.39 Bn ₹35.10 Bn RevenueFromOperations
Gross Revenue (incl. inter-segment) ₹25.90 Bn ₹28.39 Bn ₹35.10 Bn SegmentRevenueFromOperations
Other Income ₹0.76 Bn ₹1.07 Bn ₹0.72 Bn OtherIncome
Total Income ₹26.66 Bn ₹29.46 Bn ₹35.83 Bn Income
Cost of Materials Consumed ₹0.00 Bn ₹0.00 Bn ₹0.00 Bn CostOfMaterialsConsumed
Purchases of Stock-in-Trade ₹0.00 Bn ₹0.00 Bn ₹0.00 Bn PurchasesOfStockInTrade
Changes in Inventories ₹0.00 Bn ₹0.00 Bn ₹0.00 Bn ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade
Employee Benefit Expense ₹16.52 Bn ₹18.15 Bn ₹21.98 Bn EmployeeBenefitExpense
Finance Costs ₹0.49 Bn ₹0.22 Bn ₹0.19 Bn FinanceCosts
Depreciation and Amortisation ₹0.76 Bn ₹0.80 Bn ₹1.26 Bn DepreciationDepletionAndAmortisationExpense
Other Expenses ₹4.33 Bn ₹4.90 Bn ₹6.94 Bn OtherExpenses
Total Expenses ₹22.10 Bn ₹24.07 Bn ₹30.37 Bn Expenses
Profit Before Exceptional Items and Tax ₹4.56 Bn ₹5.39 Bn ₹5.45 Bn ProfitBeforeExceptionalItemsAndTax
Exceptional Items ₹0.02 Bn ₹0.00 Bn ₹-0.20 Bn ExceptionalItemsBeforeTax
Profit Before Tax ₹4.59 Bn ₹5.39 Bn ₹5.25 Bn ProfitBeforeTax
Tax Expense ₹1.22 Bn ₹1.33 Bn ₹1.24 Bn TaxExpense
Net Profit (incl. minority interest) ₹3.37 Bn ₹4.07 Bn ₹4.01 Bn ProfitLossForPeriod
Net Profit (to shareholders) ₹3.45 Bn N/A ₹4.01 Bn ProfitOrLossAttributableToOwnersOfParent
Basic EPS ₹15.19 ₹17.15 ₹16.72 BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations
Diluted EPS ₹15.07 ₹17.02 ₹16.62 DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations

Every figure above is the exact value of the named XBRL element from INDGN.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).